Ieq Capital LLC Makes New Investment in Cognex Corporation $CGNX

Ieq Capital LLC bought a new position in shares of Cognex Corporation (NASDAQ:CGNXFree Report) during the second quarter, Holdings Channel.com reports. The firm bought 99,395 shares of the scientific and technical instruments company’s stock, valued at approximately $7,198,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in Cognex during the 2nd quarter worth $26,000. Geneos Wealth Management Inc. raised its position in shares of Cognex by 402.2% during the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock worth $27,000 after acquiring an additional 736 shares during the last quarter. Elevation Wealth Partners LLC lifted its stake in shares of Cognex by 635.4% during the second quarter. Elevation Wealth Partners LLC now owns 478 shares of the scientific and technical instruments company’s stock valued at $35,000 after acquiring an additional 413 shares during the period. CIBC Private Wealth Group LLC boosted its holdings in Cognex by 74.8% in the third quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company’s stock valued at $35,000 after acquiring an additional 327 shares during the last quarter. Finally, Cassaday & Co Wealth Management LLC acquired a new stake in Cognex in the first quarter worth about $36,000. Institutional investors and hedge funds own 88.12% of the company’s stock.

Cognex Stock Performance

Cognex stock opened at $60.54 on Monday. Cognex Corporation has a 1-year low of $34.60 and a 1-year high of $72.88. The company has a fifty day simple moving average of $64.92 and a 200 day simple moving average of $58.89. The company has a market cap of $10.18 billion, a P/E ratio of 58.78 and a beta of 1.49.

Cognex (NASDAQ:CGNXGet Free Report) last posted its quarterly earnings results on Wednesday, August 5th. The scientific and technical instruments company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.42 by $0.03. The firm had revenue of $291.26 million for the quarter, compared to analyst estimates of $292.10 million. Cognex had a return on equity of 13.50% and a net margin of 16.05%.The business’s quarterly revenue was up 16.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.25 EPS. Cognex has set its FY 2026 guidance at 1.640-1.680 EPS and its Q3 2026 guidance at 0.500-0.540 EPS. On average, equities research analysts forecast that Cognex Corporation will post 1.68 EPS for the current year.

Cognex Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, September 3rd. Investors of record on Thursday, August 20th will be issued a dividend of $0.085 per share. The ex-dividend date is Thursday, August 20th. This represents a $0.34 dividend on an annualized basis and a yield of 0.6%. Cognex’s dividend payout ratio (DPR) is presently 33.01%.

Insiders Place Their Bets

In other Cognex news, VP Darren Marc Long sold 20,252 shares of the business’s stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $66.34, for a total transaction of $1,343,517.68. Following the transaction, the vice president owned 3,990 shares of the company’s stock, valued at $264,696.60. The trade was a 83.54% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.70% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on CGNX. Weiss Ratings upgraded shares of Cognex from a “hold (c)” rating to a “hold (c+)” rating in a research report on Tuesday, August 11th. Truist Financial boosted their price target on shares of Cognex from $71.00 to $78.00 and gave the stock a “hold” rating in a research note on Friday, August 7th. HSBC cut shares of Cognex from a “buy” rating to a “hold” rating and set a $65.00 price objective on the stock. in a research note on Monday, August 10th. JPMorgan Chase & Co. upgraded shares of Cognex from a “neutral” rating to an “overweight” rating and upped their target price for the company from $65.00 to $75.00 in a research report on Tuesday, May 26th. Finally, DA Davidson set a $65.00 price target on Cognex and gave the stock a “neutral” rating in a research report on Monday, August 10th. Two research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $75.64.

Get Our Latest Stock Analysis on Cognex

About Cognex

(Free Report)

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

Read More

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNXFree Report).

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.